JPH06141876A - Production of optically active n-benzyl-3-pyrrolidinol - Google Patents

Production of optically active n-benzyl-3-pyrrolidinol

Info

Publication number
JPH06141876A
JPH06141876A JP29978092A JP29978092A JPH06141876A JP H06141876 A JPH06141876 A JP H06141876A JP 29978092 A JP29978092 A JP 29978092A JP 29978092 A JP29978092 A JP 29978092A JP H06141876 A JPH06141876 A JP H06141876A
Authority
JP
Japan
Prior art keywords
benzyl
genus
pyrrolidinol
optically active
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP29978092A
Other languages
Japanese (ja)
Inventor
Kenichi Mochida
顕一 持田
Tomoko Fujimoto
友子 藤元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP29978092A priority Critical patent/JPH06141876A/en
Publication of JPH06141876A publication Critical patent/JPH06141876A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To provide method for producing optically active N-benzyl-3- pyrrolidinol which is an important intermediate for optically active compounds useful as a medicine. CONSTITUTION:This method for producing optically active N-benzyl-3- pyrrolidinol is characterized by stereoselectively reducing N-benzyl-3- pyrrolidinone in the presence of an enzymic source having the activity of stereoselectively reducing the compound.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、β−ラクタム系抗生物
質やジヒドロピリジン系化合物など医薬品として有用な
光学活性化合物の重要中間体である光学活性なN−ベン
ジル−3−ピロリジノールの製造法に関する。
TECHNICAL FIELD The present invention relates to a process for producing optically active N-benzyl-3-pyrrolidinol, which is an important intermediate of optically active compounds useful as pharmaceuticals such as β-lactam antibiotics and dihydropyridine compounds.

【0002】[0002]

【従来の技術】従来、光学活性な3−ピロリジノール誘
導体の製造法としては、大別して(1)キラルな化合物
を出発物質として合成する方法および(2)プロキラル
な化合物を出発物質として、不斉合成あるいは分割によ
って光学活性体を合成する方法の2つの方法が知られて
いる。
2. Description of the Related Art Conventionally, methods for producing optically active 3-pyrrolidinol derivatives are roughly classified into (1) a method of synthesizing a chiral compound as a starting material and (2) an asymmetric synthesis using a prochiral compound as a starting material. Alternatively, two methods of synthesizing an optically active substance by resolution are known.

【0003】(1)に関しては、ヒドロキシプロリンよ
り合成する方法(特開昭60-23328号公報)、D−リンゴ
酸から合成する方法〔ヘテロサイクルズ(Heterocycle
s), 24, 1331(1986)〕、グルタミン酸から合成する方法
〔シンセティック・コミュニケーションズ(Synth. Comm
un.), 16, 1815(1986)〕、アスパラギン酸から合成する
方法〔ヘテロサイクルズ(Heterocycles), 24, 1331(198
6)〕、グルタミンから合成する方法〔ブレティン・オブ
・ザ・ケミカル・ソサエティー・オブ・ジャパン(Bul
l. Chem. Sco. Jpn.), 51, 3296(1978)〕などが知られ
ている。
Regarding (1), a method of synthesizing from hydroxyproline (JP-A-60-23328) and a method of synthesizing from D-malic acid [Heterocycles
s), 24 , 1331 (1986)], a method of synthesizing from glutamic acid [Synth. Comms (Synth. Comm.
un.), 16 , 1815 (1986)], a method of synthesizing from aspartic acid [Heterocycles, 24 , 1331 (198).
6)], a method of synthesizing from glutamine [Bulletin of the Chemical Society of Japan (Bul
l. Chem. Sco. Jpn.), 51 , 3296 (1978)] and the like.

【0004】(2)に関しては、4−ヒドロキシ−2−
ピロリドンから合成する方法(特開平1-207266号公
報)、アミノブタノール誘導体から合成する方法 (特開
平3-176462号公報)、4−ハロ−3−ヒドロキシブタン
ニトリルのスルホン酸エステルから合成する方法(特開
平3-176463号公報)などが知られている。
Regarding (2), 4-hydroxy-2-
Method of synthesizing from pyrrolidone (JP-A-1-207266), method of synthesizing from aminobutanol derivative (JP-A-3-176462), method of synthesizing from sulfonic acid ester of 4-halo-3-hydroxybutanenitrile ( JP-A-3-176463) and the like are known.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、光学
活性なN−ベンジル−3−ピロリジノールの新規な製造
法を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a novel process for producing optically active N-benzyl-3-pyrrolidinol.

【0006】[0006]

【課題を解決するための手段】本発明によれば、N−ベ
ンジル−3−ピロリジノンを該化合物を立体選択的に還
元する活性を有する酵素源の存在下、立体選択的に還元
することを特徴とする光学活性なN−ベンジル−3−ピ
ロリジノールの製造法を提供することができる。以下、
本発明を詳細に説明する。本発明の還元反応に用いられ
る酵素源としては、N−ベンジル−3−ピロリジノンを
立体選択的に還元する活性を有する微生物の菌体、培養
物またはそれらの処理物であればいずれでも用いること
ができる。
According to the present invention, N-benzyl-3-pyrrolidinone is stereoselectively reduced in the presence of an enzyme source having the activity of stereoselectively reducing the compound. And a method for producing optically active N-benzyl-3-pyrrolidinol. Less than,
The present invention will be described in detail. As the enzyme source used in the reduction reaction of the present invention, any microorganism cells, cultures or processed products thereof having the activity of stereoselectively reducing N-benzyl-3-pyrrolidinone may be used. it can.

【0007】このような活性を有する微生物としては、
例えば、アセトバクター(Acetobacter)属、コリネバク
テリウム(Corynebacterium)属、グルコノバクター(Gluc
onobacter)属、シュードモナス(Pseudomonas)属、バチ
ラス(Bacillus)属、エシェリヒア(Escherichia)属、ブ
レビバクテリウム(Brevibacterium)属、アスペルギルス
(Aspergillus)属、シエラビア(Thielavia)属、サッカロ
マイコプシス(Saccharomycopsis)属、サッカロマイセス
(Saccharomyces)属、パチソレン(Pachysolen)属、ロド
トルラ(Rhodotorula)属、キャンディダ(Candida)属、マ
イコバクテリウム(Mycobacterium)属、ロドコッカス(Rh
odococcus)属、アクチノプレインズ(Actinoplanes)属、
アミコラタ(Amycolata)属、キタサトスポリア(Kitasato
sporia)属、シトロバクター(Citrobacter)属、アミコラ
トプシス (Amycolatopsis)属、ビブリオ(Vibrio)属、フ
ェロマイセス(Fellomyces)属、ノカルディオプシス(Noc
ardiopsis)属などに属する微生物があげられる。このよ
うな微生物は一般に、入手または購入が容易である保存
株から得ることができる。また、自然界から分離するこ
ともできる。なお、これらの微生物に変異を生じさせて
生産性の高い菌株を得ることもできる。
Microorganisms having such activity include:
For example, genus Acetobacter, genus Corynebacterium, Gluconobacter
onobacter genus, Pseudomonas genus, Bacillus genus, Escherichia genus, Brevibacterium genus, Aspergillus
(Aspergillus) genus, Sierravia (Thielavia) genus, Saccharomycopsis (Saccharomycopsis) genus, Saccharomyces
(Saccharomyces) genus, Pachysolen genus, Rhodotorula genus, Candida genus, Mycobacterium genus (Mycobacterium) genus, Rhodococcus (Rh
genus odococcus), genus Actinoplanes,
The genus Amycolata, Kitasato
sporia genus, Citrobacter genus, Amycolatopsis genus, Vibrio genus, Fellomyces genus, Nocardiopsis (Noc
Microorganisms belonging to the genus Ardiopsis) and the like. Such microorganisms can generally be obtained from stock strains that are easy to obtain or purchase. It can also be separated from nature. It is also possible to mutate these microorganisms to obtain highly productive strains.

【0008】前記微生物の培養により得られる菌体の処
理物としては、菌体の乾燥物、界面活性剤または有機溶
剤添加物、溶菌酵素処理物、固定化菌体あるいは菌体か
らの抽出酵素標品などがあげられる。また、培養物の処
理物としては、培養物の濃縮物、乾燥物、界面活性剤ま
たは有機溶剤添加物、溶菌酵素処理物などがあげられ
る。さらに、培養菌体、培養物より酵素を精製し、これ
を使用してもよい。
[0008] Examples of the treated product of bacterial cells obtained by culturing the above-mentioned microorganisms include dried bacterial cells, additives of surfactants or organic solvents, treated products of lytic enzymes, immobilized bacterial cells or enzyme extracted from bacterial cells. Goods are given. Examples of the processed product of the culture include a concentrated product, a dried product, a surfactant or an organic solvent additive, and a lytic enzyme-processed product. Furthermore, the enzyme may be purified from the cultured bacterial cell or culture and used.

【0009】本発明に用いる微生物の培養は、通常、振
盪培養あるいは通気撹絆深部培養などの好気的条件下で
行う。培地としては、使用菌株が資化し得る炭素源、窒
素源、無機塩および微量有機栄養源を程良く含有するも
のならば、合成培地または天然培地いずれも用いること
ができる。
Cultivation of the microorganism used in the present invention is generally carried out under aerobic conditions such as shaking culture or aeration-agitation deep culture. As the medium, either a synthetic medium or a natural medium can be used, so long as it contains a carbon source, a nitrogen source, an inorganic salt and a trace amount of organic nutrient source which can be assimilated by the strain used.

【0010】炭素源としては、グルコース、マルトー
ス、デンプン加水分解物、糖蜜などの炭水化物が使用で
きる。窒素源としては、アンモニア、硫酸アンモニウ
ム、塩化アンモニウムなどの各種の無機および有機のア
ンモニウム塩類、または、肉エキス、酵母エキス、麦芽
エキス、ペプトン、ポリペプトン、コーンスティープリ
カー、カゼイン加水分解物などの窒素含有有機物などが
使用できる。
As the carbon source, carbohydrates such as glucose, maltose, starch hydrolyzate and molasses can be used. As the nitrogen source, various inorganic and organic ammonium salts such as ammonia, ammonium sulfate and ammonium chloride, or nitrogen-containing organic substances such as meat extract, yeast extract, malt extract, peptone, polypeptone, corn steep liquor and casein hydrolyzate. Etc. can be used.

【0011】無機塩としては、硫酸マグネシウム、硫酸
第一鉄、硫酸マンガン、塩化亜鉛、塩化カリウム、塩化
コバルトなどが使用できる。他に微量元素としてモリブ
デン、タングステン、ストロンチウムなどの塩類を加え
てもよい。培養温度は20〜37℃、培養pHは6〜9
で、1〜14日間培養する。
As the inorganic salt, magnesium sulfate, ferrous sulfate, manganese sulfate, zinc chloride, potassium chloride, cobalt chloride and the like can be used. In addition, salts such as molybdenum, tungsten and strontium may be added as trace elements. Culture temperature is 20-37 ° C, culture pH is 6-9.
Incubate for 1 to 14 days.

【0012】本発明の基質となるN−ベンジル−3−ピ
ロリジノンは特開昭54−16466号公報に記載の方
法に準じて合成することができる。本発明のN−ベンジ
ル−3−ピロリジノンの立体選択的な還元は、水性媒体
中、前記微生物の菌体、培養物もしくはそれらの処理物
とN−ベンジル−3−ピロリジノンとを混合し、攪拌ま
たは振盪することにより行われる。
The substrate of the present invention, N-benzyl-3-pyrrolidinone, can be synthesized according to the method described in JP-A-54-16466. The stereoselective reduction of N-benzyl-3-pyrrolidinone of the present invention is carried out by mixing N-benzyl-3-pyrrolidinone with the microbial cells, culture or treated product thereof in an aqueous medium and stirring or It is performed by shaking.

【0013】水性媒体としては、水または水とエタノー
ル、アセトン、ジオキサン、テトラヒドロフラン、ジメ
チルホルムアミドなどの混合溶媒が用いられる。基質で
あるN−ベンジル−3−ピロリジノンは、反応液に対し
て0.1〜50重量%用いられ、微生物菌体処理物等は
基質に対して1〜500重量%用いられる。このとき、
基質であるN−ベンジル−3−ピロリジノンの分散性を
向上させるためにノニオン(日本油脂製)、スパン(関
東化学社製)、トリトン(半井化学社製)などの界面活
性剤を添加することもできる。さらに、反応液のpHを
一定に保つために、燐酸ナトリウム、燐酸カリウムなど
の無機酸塩の緩衝液または酢酸ナトリウム、クエン酸ナ
トリウムなどの有機酸塩の緩衝液などを用いることもで
きる。また必要に応じて、水酸化ナトリウムなどの塩基
を添加することもできる。
As the aqueous medium, water or a mixed solvent of water and ethanol, acetone, dioxane, tetrahydrofuran, dimethylformamide or the like is used. The substrate, N-benzyl-3-pyrrolidinone, is used in an amount of 0.1 to 50% by weight based on the reaction solution, and the treated product of microbial cells is used in an amount of 1 to 500% by weight based on the substrate. At this time,
In order to improve the dispersibility of N-benzyl-3-pyrrolidinone, which is a substrate, a surfactant such as nonion (Nippon Oil & Fats Co., Ltd.), Span (Kanto Chemical Co., Inc.), Triton (Hanai Chemical Co., Ltd.) may be added. it can. Furthermore, in order to keep the pH of the reaction solution constant, a buffer solution of an inorganic acid salt such as sodium phosphate or potassium phosphate or a buffer solution of an organic acid salt such as sodium acetate or sodium citrate can be used. If necessary, a base such as sodium hydroxide can be added.

【0014】反応は温度0〜70℃、好ましくは20〜
50℃、pH4〜9の条件で行われる。反応時間は用い
る基質濃度、微生物菌体量、反応温度などによって異な
るが、通常1〜100時間で終了する。反応液から目的
物を単離精製するには、微生物菌体などを除去した後、
溶媒抽出、洗浄、濃縮、シリカゲルカラムクロマトグラ
フィーなどによって行うことができる。
The reaction temperature is 0 to 70 ° C., preferably 20 to
It is carried out under the conditions of 50 ° C. and pH 4-9. The reaction time varies depending on the substrate concentration used, the amount of microbial cells, the reaction temperature, etc., but it is usually completed in 1 to 100 hours. To isolate and purify the desired product from the reaction solution, after removing microbial cells,
It can be performed by solvent extraction, washing, concentration, silica gel column chromatography and the like.

【0015】このようにして得られるN−ベンジル−3
−ピロリジノールは、(5R,6S)−2−〔(S)−
1−(アセトイミドイル)ピロリジン−3−イルチオ〕
−6−〔(R)−1−ヒドロキシエチル〕カルバペン−
2−エム−3−カルボン酸(特開昭60-19764号公報)な
どのβ−ラクタム系抗生物質や、(3S)−1−ベンジ
ル−3−ピロリジニルメチル(4S)−2,6−ジメチ
ル−4−(m−ニトロフェニル)−1,4−ジヒドロピ
リジン−3,5−ジカルボキシレート〔化合物(I);
ジャーナル・オブ・メディシナル・ケミストリー(J. Me
d. Chem.),29,2504(1986)〕などのジヒドロピリジン系
化合物の合成中間体として有用である。例えば、化合物
(I)は、光学活性なN−ベンジル−3−ピロリジノー
ルからジャーナル・オブ・メディシナル・ケミストリー
,29, 2504(1986)に記載の方法に従い製造することがで
きる。
N-benzyl-3 thus obtained
-Pyrrolidinol is (5R, 6S) -2-[(S)-
1- (acetimidoyl) pyrrolidin-3-ylthio]
-6-[(R) -1-hydroxyethyl] carbapene-
Β-lactam antibiotics such as 2-em-3-carboxylic acid (JP-A-60-19764) and (3S) -1-benzyl-3-pyrrolidinylmethyl (4S) -2,6- Dimethyl-4- (m-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylate [Compound (I);
Journal of Medicinal Chemistry (J. Me
d. Chem.), 29 , 2504 (1986)] and the like, which are useful as synthetic intermediates for dihydropyridine compounds. For example, compound (I) is prepared from optically active N-benzyl-3-pyrrolidinol by Journal of Medicinal Chemistry.
, 29 , 2504 (1986).

【0016】以下の実施例により本発明の態様を説明す
る。
The following examples illustrate aspects of the present invention.

【0017】[0017]

【実施例】【Example】

実施例1 ペプトン2%、肉エキス0.7%、酵母エキス0.5%、
食塩0.3%(pH7.2)の組成から成る培地30ml
を300ml容量の三角フラスコに入れ、滅菌後、第1
表に示す菌株を各々植菌し、28℃で24時間振盪培養
を行った。培養終了後、培養物を遠心分離(10,000rpm,
5分間)し、菌体を集め生理食塩水で洗浄した。この菌
体をトリトンX100を0.5%含む0.1Mリン酸緩衝
液(pH7)3mlに懸濁し、N−ベンジル−3−ピロ
リジノン12mgを含む0.06mlのエタノールを加
え、30℃にて24時間振盪した。反応終了後、反応液
を酢酸エチルで抽出し、高速液体クロマトグラフィー
(HPLC)にて生成したN−ベンジル−3−ピロリジ
ノールの転換率、光学純度を測定した。HPLCの条件
は以下の通りである。
Example 1 Peptone 2%, meat extract 0.7%, yeast extract 0.5%,
30 ml of medium consisting of 0.3% salt (pH 7.2)
In a Erlenmeyer flask with a capacity of 300 ml and after sterilization,
Each of the strains shown in the table was inoculated and shake-cultured at 28 ° C. for 24 hours. After completion of the culture, the culture was centrifuged (10,000 rpm,
After 5 minutes), the bacterial cells were collected and washed with physiological saline. The cells were suspended in 3 ml of 0.1 M phosphate buffer (pH 7) containing 0.5% Triton X100, 0.06 ml of ethanol containing 12 mg of N-benzyl-3-pyrrolidinone was added, and the suspension was added at 30 ° C. for 24 hours. Shake for hours. After the reaction was completed, the reaction solution was extracted with ethyl acetate, and the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by high performance liquid chromatography (HPLC) were measured. The HPLC conditions are as follows.

【0018】HPLC カラム キラルセルOD(ダイ
セル社製)、溶出溶媒 ヘキサン:イソプロパノール:
ジエチルアミン=95:5:0.1、流速 1ml/
分、検出 UV254nm吸収 結果を第1表に示す。
HPLC column Chiralcel OD (manufactured by Daicel), elution solvent hexane: isopropanol:
Diethylamine = 95: 5: 0.1, flow rate 1 ml /
Min., Detection UV254 nm absorption results are shown in Table 1.

【0019】[0019]

【表1】 [Table 1]

【0020】実施例2 麦芽エキス2%、グルコース2%、ペプトン0.1%
(pH6)の組成から成る培地30mlを300ml容
量の三角フラスコに入れ、滅菌後、第2表に示す菌株を
各々植菌し、28℃で4日間振盪培養を行った。培養終
了後、培養物を遠心分離(10,000rpm,5分間)し、菌体
を集め生理食塩水で洗浄した。この菌体をトリトンX1
00を0.5%含む0.1Mリン酸緩衝液(pH7)3m
lに懸濁し、N−ベンジル−3−ピロリジノン12mg
を含む0.06mlのエタノールを加え、30℃にて2
4時間振盪した。反応終了後、反応液を酢酸エチルで抽
出し、HPLCにて生成したN−ベンジル−3−ピロリ
ジノールの転換率、光学純度を測定した。なお、HPL
Cの条件は実施例1と同様である。結果を第2表に示
す。
Example 2 Malt extract 2%, glucose 2%, peptone 0.1%
30 ml of a medium having a composition of (pH 6) was placed in a 300 ml Erlenmeyer flask, and after sterilization, the strains shown in Table 2 were inoculated and shake culture was performed at 28 ° C. for 4 days. After completion of the culture, the culture was centrifuged (10,000 rpm, 5 minutes) to collect the bacterial cells, which were washed with physiological saline. This bacterium is Triton X1
0.1M phosphate buffer (pH 7) 3m containing 0.5% of 00
12 mg of N-benzyl-3-pyrrolidinone
Add 0.06 ml ethanol containing
Shake for 4 hours. After completion of the reaction, the reaction solution was extracted with ethyl acetate, and the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by HPLC were measured. In addition, HPL
The conditions of C are the same as in Example 1. The results are shown in Table 2.

【0021】[0021]

【表2】 [Table 2]

【0022】実施例3 ペプトン2%、肉エキス0.7%、酵母エキス0.5%、
食塩0.3%(pH7.2)の組成から成る培地30ml
を300ml容量の三角フラスコに入れ、滅菌後、Acet
obacter aceti IFO 3288 を植菌し、28℃で24時間
振盪培養を行った。培養終了後、培養物を遠心分離(1
0,000rpm,5分間)し、菌体を集め生理食塩水で洗浄し
た。この菌体をトリトンX100を0.5%含む0.1M
リン酸緩衝液(pH7)3mlに懸濁し、N−ベンジル
−3−ピロリジノン12mgを含む0.06mlのエタ
ノールと27mgのグルコースを加え、30℃にて24
時間振盪した。反応終了後、反応液を酢酸エチルで抽出
し、HPLCにて生成したN−ベンジル−3−ピロリジ
ノールの転換率、光学純度を測定したところ、転換率>
95%、光学純度60%eeで(R)異性体を得た。な
お、HPLCの条件は実施例1と同様である。
Example 3 Peptone 2%, meat extract 0.7%, yeast extract 0.5%,
30 ml of medium consisting of 0.3% salt (pH 7.2)
Place in a 300 ml Erlenmeyer flask, sterilize, and
Bacteria aceti IFO 3288 was inoculated and shake culture was performed at 28 ° C. for 24 hours. After culturing, the culture is centrifuged (1
Then, the cells were collected and washed with physiological saline. This cell contains 0.1% Triton X100 in 0.1M
Suspended in 3 ml of phosphate buffer (pH 7), added 0.06 ml of ethanol containing 12 mg of N-benzyl-3-pyrrolidinone and 27 mg of glucose, and added thereto at 30 ° C. for 24 hours.
Shake for hours. After completion of the reaction, the reaction solution was extracted with ethyl acetate, and the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by HPLC were measured.
The (R) isomer was obtained with 95% and an optical purity of 60% ee. The HPLC conditions are the same as in Example 1.

【0023】実施例4 グルコース1%、ペプトン0.5%、酵母エキス0.3
%、麦芽エキス0.3%(pH6)の組成から成る培地
30mlを300ml容量の三角フラスコに入れ、滅菌
後、第3表に示す菌株を各々植菌し、28℃で24時間
振盪培養を行った。培養終了後、培養物を遠心分離(1
0,000rpm,5分間)し、菌体を集め生理食塩水で洗浄し
た。この菌体をトリトンX100を0.5%含む0.1M
リン酸緩衝液(pH7)3mlに懸濁し、N−ベンジル
−3−ピロリジノン12mgを含む0.06mlのエタ
ノールを加え、30℃にて24時間振盪した。反応終了
後、反応液を酢酸エチルで抽出し、HPLCにて生成し
たN−ベンジル−3−ピロリジノールの転換率、光学純
度を測定した。なお、HPLCの条件は実施例1と同様
である。結果を第3表に示す。
Example 4 1% glucose, 0.5% peptone, 0.3 yeast extract
%, Malt extract 0.3% (pH 6) in a medium of 30 ml was placed in a 300 ml Erlenmeyer flask, and after sterilization, each strain shown in Table 3 was inoculated and shake culture was carried out at 28 ° C. for 24 hours. It was After culturing, the culture is centrifuged (1
Then, the cells were collected and washed with physiological saline. This cell contains 0.1% Triton X100 in 0.1M
The suspension was suspended in 3 ml of a phosphate buffer (pH 7), 0.06 ml of ethanol containing 12 mg of N-benzyl-3-pyrrolidinone was added, and the mixture was shaken at 30 ° C. for 24 hours. After completion of the reaction, the reaction solution was extracted with ethyl acetate, and the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by HPLC were measured. The HPLC conditions are the same as in Example 1. The results are shown in Table 3.

【0024】[0024]

【表3】 [Table 3]

【0025】実施例5 ダイスドポテト30%、グルコース2%(pH6)の組
成から成る培地30mlを300ml容量の三角フラス
コに入れ、滅菌後、Aspergillus sydowi IFO 4284 を植
菌し、28℃で8日間振盪培養を行った。培養終了後、
培養物を遠心分離(10,000rpm,5分間)し、菌体を集め
生理食塩水で洗浄した。この菌体をトリトンX100を
0.5%含む0.1Mリン酸緩衝液(pH7)3mlに懸
濁し、N−ベンジル−3−ピロリジノン12mgを含む
0.06mlのエタノールを加え、30℃にて24時間
振盪した。反応終了後、反応液を酢酸エチルで抽出し、
HPLCにて生成したN−ベンジル−3−ピロリジノー
ルの転換率、光学純度を測定したところ、転換率>95
%、光学純度>95%eeで(R)異性体を得た。な
お、HPLCの条件は実施例1と同様である。
Example 5 30 ml of a medium having a composition of 30% diced potato and 2% glucose (pH 6) was placed in an Erlenmeyer flask having a capacity of 300 ml, sterilized, Aspergillus sydowi IFO 4284 was inoculated, and shake culture was performed at 28 ° C. for 8 days. I went. After culturing,
The culture was centrifuged (10,000 rpm, 5 minutes), the bacterial cells were collected and washed with physiological saline. The cells were suspended in 3 ml of 0.1 M phosphate buffer (pH 7) containing 0.5% Triton X100, 0.06 ml of ethanol containing 12 mg of N-benzyl-3-pyrrolidinone was added, and the suspension was added at 30 ° C. for 24 hours. Shake for hours. After completion of the reaction, the reaction solution was extracted with ethyl acetate,
When the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by HPLC were measured, the conversion rate was> 95.
%, Optical purity> 95% ee to give the (R) isomer. The HPLC conditions are the same as in Example 1.

【0026】実施例6 グルコース1%、ペプトン2%、肉エキス0.7%、酵
母エキス0.5%、食塩0.3%(pH7.2)の組成か
ら成る培地30mlを300ml容量の三角フラスコに
入れ、滅菌後、第4表に示す菌株を各々植菌し、28℃
で2日間振盪培養を行った。培養終了後、培養物を遠心
分離(10,000rpm,5分間)し、菌体を集め生理食塩水で
洗浄した。この菌体をトリトンX100を0.5%含む
0.1Mリン酸緩衝液(pH7)3mlに懸濁し、N−
ベンジル−3−ピロリジノン12mgを含む0.06m
lのエタノールを加え、30℃にて24時間振盪した。
反応終了後、反応液を酢酸エチルで抽出し、HPLCに
て生成したN−ベンジル−3−ピロリジノールの転換
率、光学純度を測定した。なお、HPLCの条件は実施
例1と同様である。結果を第4表に示す。
Example 6 30 ml of medium consisting of 1% glucose, 2% peptone, 0.7% meat extract, 0.5% yeast extract and 0.3% salt (pH 7.2) was added to a 300 ml Erlenmeyer flask. After sterilization, inoculate the strains shown in Table 4 to 28 ° C.
Shaking culture was carried out for 2 days. After completion of the culture, the culture was centrifuged (10,000 rpm, 5 minutes) to collect the bacterial cells, which were washed with physiological saline. The cells were suspended in 3 ml of 0.1 M phosphate buffer (pH 7) containing 0.5% Triton X100 to give N-.
0.06 m containing 12 mg of benzyl-3-pyrrolidinone
l of ethanol was added, and the mixture was shaken at 30 ° C. for 24 hours.
After completion of the reaction, the reaction solution was extracted with ethyl acetate, and the conversion rate and optical purity of N-benzyl-3-pyrrolidinol produced by HPLC were measured. The HPLC conditions are the same as in Example 1. The results are shown in Table 4.

【0027】[0027]

【表4】 [Table 4]

【0028】[0028]

【発明の効果】本発明によれば、β−ラクタム系抗生物
質やジヒドロピリジン系化合物など医薬品として有用な
光学活性化合物の重要中間体である光学活性なN−ベン
ジル−3−ピロリジノールを高収率で製造することがで
きる。
According to the present invention, optically active N-benzyl-3-pyrrolidinol, which is an important intermediate of optically active compounds useful as pharmaceuticals such as β-lactam antibiotics and dihydropyridine compounds, can be obtained in high yield. It can be manufactured.

フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 17/10 C12R 1:01) (C12P 17/10 C12R 1:38) (C12P 17/10 C12R 1:07) (C12P 17/10 C12R 1:185) (C12P 17/10 C12R 1:13) (C12P 17/10 C12R 1:66) (C12P 17/10 C12R 1:645) (C12P 17/10 C12R 1:85) (C12P 17/10 C12R 1:72) (C12P 17/10 C12R 1:32) (C12P 17/10 C12R 1:63) (C12P 17/10 C12R 1:365) Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location (C12P 17/10 C12R 1:01) (C12P 17/10 C12R 1:38) (C12P 17/10 C12R 1: 07) (C12P 17/10 C12R 1: 185) (C12P 17/10 C12R 1:13) (C12P 17/10 C12R 1:66) (C12P 17/10 C12R 1: 645) (C12P 17/10 C12R 1: 85) (C12P 17/10 C12R 1:72) (C12P 17/10 C12R 1:32) (C12P 17/10 C12R 1:63) (C12P 17/10 C12R 1: 365)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 N−ベンジル−3−ピロリジノンを該化
合物を立体選択的に還元する活性を有する酵素源の存在
下、立体選択的に還元することを特徴とする光学活性な
N−ベンジル−3−ピロリジノールの製造法。
1. An optically active N-benzyl-3, which is characterized in that N-benzyl-3-pyrrolidinone is stereoselectively reduced in the presence of an enzyme source having an activity of stereoselectively reducing the compound. -Method for producing pyrrolidinol.
【請求項2】 酵素源がアセトバクター属、コリネバク
テリウム属、グルコノバクター属、シュードモナス属、
バチラス属、エシェリヒア属、ブレビバクテリウム属、
アスペルギルス属、シエラビア属、サッカロマイコプシ
ス属、サッカロマイセス属、パチソレン属、ロドトルラ
属、キャンディダ属、マイコバクテリウム属、ロドコッ
カス属、アクチノプレインズ属、アミコラタ属、キタサ
トスポリア属、シトロバクター属、アミコラトプシス
属、ビブリオ属、フェロマイセス属、ノカルディオプシ
ス属に属し、N−ベンジル−3−ピロリジノンを立体選
択的に還元する活性を有する微生物の菌体、培養物また
はそれらの処理物である請求項1記載の製造法。
2. The enzyme source is Acetobacter, Corynebacterium, Gluconobacter, Pseudomonas,
Bacillus, Escherichia, Brevibacterium,
Aspergillus, Sierravia, Saccharomycopsis, Saccharomyces, Patissolen, Rhodotorula, Candida, Mycobacterium, Rhodococcus, Actinoplanes, Amycolata, Kitasatosporia, Citrobacter, Amycolatopsis A microbial cell, a culture, or a processed product thereof, which belongs to the genus Genus, the genus Vibrio, the genus Ferromyces, or the genus Nocardiopsis and has the activity of stereoselectively reducing N-benzyl-3-pyrrolidinone. Manufacturing method.
JP29978092A 1992-11-10 1992-11-10 Production of optically active n-benzyl-3-pyrrolidinol Withdrawn JPH06141876A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29978092A JPH06141876A (en) 1992-11-10 1992-11-10 Production of optically active n-benzyl-3-pyrrolidinol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29978092A JPH06141876A (en) 1992-11-10 1992-11-10 Production of optically active n-benzyl-3-pyrrolidinol

Publications (1)

Publication Number Publication Date
JPH06141876A true JPH06141876A (en) 1994-05-24

Family

ID=17876867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29978092A Withdrawn JPH06141876A (en) 1992-11-10 1992-11-10 Production of optically active n-benzyl-3-pyrrolidinol

Country Status (1)

Country Link
JP (1) JPH06141876A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023769A1 (en) * 1996-11-26 1998-06-04 Kaneka Corporation Process for the preparation of n-benzyl-3-pyrrolidinol
WO1998023768A1 (en) * 1996-11-26 1998-06-04 Kaneka Corporation Process for the preparation of optically active n-benzyl-3-pyrrolidinol
WO2002010399A1 (en) * 2000-08-01 2002-02-07 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
EP1553170A1 (en) * 2002-09-19 2005-07-13 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
WO2007024113A1 (en) 2005-08-25 2007-03-01 Rstech Corporation Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
WO2010058429A1 (en) 2008-11-24 2010-05-27 Council Of Scientific & Industrial Research A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023769A1 (en) * 1996-11-26 1998-06-04 Kaneka Corporation Process for the preparation of n-benzyl-3-pyrrolidinol
WO1998023768A1 (en) * 1996-11-26 1998-06-04 Kaneka Corporation Process for the preparation of optically active n-benzyl-3-pyrrolidinol
US6214610B1 (en) * 1996-11-26 2001-04-10 Kaneka Corporation Process for the preparation of optically active N-benzyl-3-pyrrolidinol
WO2002010399A1 (en) * 2000-08-01 2002-02-07 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
JP4880859B2 (en) * 2000-08-01 2012-02-22 株式会社カネカ Novel carbonyl reductase, its gene, and its use
US7033808B2 (en) 2000-08-01 2006-04-25 Kaneka Corporation Carbonyl reductase, gene thereof and method of using the same
EP1553170A4 (en) * 2002-09-19 2006-05-31 Kaneka Corp Novel carbonyl reductase, gene thereof and method of using the same
US7220564B2 (en) 2002-09-19 2007-05-22 Kaneka Corporation Carbonyl reductase, gene thereof and method of using the same
US7531329B2 (en) 2002-09-19 2009-05-12 Kaneka Corporation Carbonyl reductase, gene thereof and method of using the same
EP1553170A1 (en) * 2002-09-19 2005-07-13 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
WO2007024113A1 (en) 2005-08-25 2007-03-01 Rstech Corporation Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity
WO2010058429A1 (en) 2008-11-24 2010-05-27 Council Of Scientific & Industrial Research A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines
US8445700B2 (en) 2008-11-24 2013-05-21 Council Of Scientific & Industrial Research Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines

Similar Documents

Publication Publication Date Title
EP0449648B1 (en) Process for producing R(-)-mandelic acid and derivatives thereof
EP0527553B1 (en) Process for producing r(-)-mandelic acid and derivative thereof
JP4394647B2 (en) Method for producing optically active tetrahydrothiophene derivative and method for crystallizing optically active tetrahydrothiophene-3-ol
EP0610048A2 (en) Process for producing optically active alpha-hydrocarboxylic acid having phenyl group
JP3891522B2 (en) Process for producing optically active 3-quinuclidinol
JPH06141876A (en) Production of optically active n-benzyl-3-pyrrolidinol
JPH06209781A (en) Production of optically active alcohol
US5441888A (en) Process for producing D-mandelic acid from benzoylformic acid
JPH05199889A (en) Production of @(3754/24)s)-1-phenyl-1,3-propanediol or its derivative
JP2698627B2 (en) Method for producing optically active amines and derivatives thereof
JP2005117905A (en) Method for producing optically active 1-benzyl-3-pyrrolidinol
EP0751224B1 (en) Process for producing (r)-2-amino-1-phenylethanol or halogenated derivative thereof, process for producing optically active phenylserine or halogenated derivative thereof, and novel compound 3-(3-chlorophenyl)serine
EP0655504A2 (en) Process for optical resolution of 1,2-diol derivatives
JP2786500B2 (en) Production method of optically active 1,3-butanediol
JP2840723B2 (en) Method for producing 4-halo-3-hydroxybutyronitrile
JP2946054B2 (en) Process for producing optically active (R)-(-)-3-halo-1,2-propanediol
JP3078597B2 (en) Method for producing L-threo-3- (3,4-dihydroxyphenyl) serine derivative
JPH01222798A (en) Production of optically active carboxylic acid and antipode ester thereof
JPH04341195A (en) Production of optically active mandelic acid
JP2946055B2 (en) Method for producing optically active (S)-(+)-3-halo-1,2-propanediol
JPH06261787A (en) Production of optically active beta-amino acid
JP2828720B2 (en) Method for producing optically active 1,3-butanediol
JP2693536B2 (en) Process for producing (7R) -cyclopenta [d] pyrimidine derivative
JP3169729B2 (en) Method for producing optically active secondary alcohol
JP3893721B2 (en) Method for producing optically active compound

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20000201